Country Information


Ghana

 
HIV prevalence 15-49, 2007/2008 1.9%
Tuberculosis death rate 50/100,000 population
Malaria death rate (children under 5) 448/100,000 population
 
   
             
     
  Ghana is a West African country with a population close to 20 million and an annual per capita income of about $270. Ghana is a major regional trading partner of the US, and one of the leading nations of West Africa. Gold, timber and cocoa are major exports, and many Ghanaians practice subsistence agriculture. Ghana has been politically stable over the last decade, with several democratic elections taking place, including an orderly transfer of power from one party to another in 2000.

According to a November 2003 AllAfrica.com interview with Professor Sakyi Awuku Amoa, the head of Ghana's AIDS Commission, the HIV-positive rate among Ghanaian adults is at 3.4 percent and rising rapidly. HIV-prevalence in the city of Koforidua has gone up to 8.5 percent, and prevalence rates in several other cities have gone over 6 percent. (The most recent UNAIDS data for Ghana as a whole had the rate at 3.0 percent; Synergy reported a HIV prevalence in Ghana within a range of 2.8 to 4.2 percent.) HIV prevalence rates are higher in the more heavily populated southeast of the country, and women account for 63 percent of AIDS cases.

The incidence of TB in Ghana has risen dramatically in the last decade; currently there are about 30,000 TB cases each year and 15,000 people die of the disease. In 1995 Ghana had only 2,195 cases of TB. The spread of TB from cattle to humans has become a major problem, and multi-drug resistant TB (MDRTB) is on the rise.

As in many other African nations in the tropical belt, malaria is the leading cause of death in Ghana for children under five. In 2000 WHO estimated a mortality rate of 448 per 100,000 for children under five. The GFATM estimates that only three percent of Ghanaians sleep under insecticide treated nets (ITNs), whereas 25 to 40 percent of people in other African countries with high malaria prevalence use ITNs.

A major concern for Ghana's health infrastructure is the exodus of its trained medical personnel. According to a 2002 report, over 30 percent of all health professionals trained in Ghana during 1993-2002 left the country. Doctors were much more likely to leave than nurses, with 604 of 871 doctors trained during the period leaving the country.

Sources: USAID; www.geographic.org; United Nations Statistics Division; AllAfrica.com: Public Agenda, July 3, 2003, posted to the web July 7, 2003; AllAfrica.com, Interview with Professor Amoa, November 30, 2003; Synergy Project; IRIN

 
           
             
  The centerpiece of Ghana's national health policy is currently a five year Program of Work for 2002-2006, with the theme, "Partnerships for Health: Bridging the Inequality Gap." The central objective of this policy is to improve health care for Ghana's poor. A component of this program is the creation of a National Health Insurance Plan that Vice President Alhaji Mahama announced would be launched in 2003. In addition to its general health policies, Ghana has adopted a National HIV/AIDS Strategic Framework for 2001-2005. Ghana's AIDS Commission is working with The AIDS Support Organization (TASO) in Uganda in order to learn from the successes that country has had in fighting HIV/AIDS.

Over the last decade Ghana has consistently spent about 10 percent of its national budget on health. In the 1990s a World Bank analysis found a number of shortcomings in Ghana's health sector:

  • too many resources were devoted to curative care relative to preventative care
  • too high a proportion of funds were spent on salaries relative to drugs and other medical supplies
  • high user fees and other barriers prevented many Ghanaians from gaining access to care.

To address these and other shortcomings in its health sector, in 1997 Ghana adopted a five year Program of Work aimed at improving the availability, efficiency and quality of health services. The government of Ghana provided $360 million for this program, bilateral donors $240 million, and the World Bank $50 million. Gains under that program were "slow and uneven", in the assessement of Danida, one of the bilateral donors. The 1997-2001 program was a precursor to the current effort to bridge the health-care gap in Ghana.

The treatment of TB in Ghana is a particular area where gains can be made. The WHO estimated in 2000 that only 55 percent of TB cases in Ghana were diagnosed and treated under DOTS protocols.

Ghana's Health Ministry is working to fight malaria by providing a 60 percent discount on ITNs for pregnant and nursing women.

Sources: Ghana Health Service; Danida; United Nations Statistics Division; IRIN

 
           
             
 
Total population. mid-2009 23.8 (millions)
HIV prevalence 15-49, 2007/2008 1.9%
Tuberculosis death rate 50/100,000 population
Prevalence of tuberculosis per 100,000 population, 2000 389
Prevalence of tuberculosis per 100,000 population, 2004 376
% Tuberculosis detection rate under DOTS, 2001 42
% Tuberculosis detection rate under DOTS, 2004 37
% Tuberculosis treatment success rate under DOTS, 2000 51
% Tuberculosis treatment success rate under DOTS, 2003 66
Malaria death rate (children under 5) 448/100,000 population
GNI PPP Per Capita, 2008 1,430 (US$)
Life expectancy at birth 59 years
Infant mortality rate 50/1,000 live births
Total fertility rate 4.0 per woman
Crude birth rate 31/1,000 population
Crude death rate 10/1,000 population
Adult male literacy level 94% (pct. 15+ literate)
Adult female literacy level 89% (pct. 15+ literate)
Contraceptive prevalence rate, modern methods 17% of women in union
Estimated number of people living with HIV: Adults and Children, 2005 320,000
Estimated number of people living with HIV: Adults and children, end 2003 350,000
Estimated number of people living with HIV: Adults and children, end 2001 330,000
Estimated number of people living with HIV: Adults (15+), 2005 300,000
Estimated number of people living with HIV: Adults (15-49), end 2003 320,000
Estimated number of people living with HIV: Adults (15-49), end 2001 310,000
Estimated number of people living with HIV: Adults (15-49) rate (%), 2005 2.2%
Estimated number of people living with HIV: Women (15+), 2005 180,000
Estimated number of people living with HIV: Women 15-49, end 2003 180,000
Estimated number of people living with HIV: Women 15-49, end 2001 170,000
Estimated number of people living with HIV: Children (0-14), 2005 25,000
Estimated number of people living with HIV: Children (0-14), end 2003 24,000
Estimated number of people living with HIV: Children (0-14), end 2001 22,000
Estimated number of AIDS deaths: Adults and children, 2005 29,000
AIDS deaths in adults and children, end 2003 30,000
AIDS deaths in adults and children, end 2001 26,000
Estimated number of orphans due to AIDS: Children (0-17), 2005 170,000
Orphans due to AIDS (0-17), living 2003 170,000
Orphans due to AIDS (0-17), living 2001 140,000
% Women (15-49), currently married or living with a partner, who have ever discussed AIDS prevention with their husband or partner 60%

Demographic data contained in this section was obtained from the following sources: The Population Reference Bureau’s 2009 World Population Data Sheet was used for total population, life expectancy at birth, infant mortality, fertility, birth rate, death rate, % of married women 15-49 using modern methods of contraception, % of population 15-49 with HIV/AIDS in 2007/2008, and the GNI PPP per capita (2008). Literacy rates were found in the Population Reference Bureau’s publication 2005 Women of Our World. HIV prevalence data for 2001 and 2003 was obtained from the UNAIDS Barcelona 2002 report; HIV prevalence and orphan data for 2005 was obtained from the UNAIDS Report on the Global AIDS Epidemic 2006. Data on the % women who have discussed AIDS prevention with their husband or partner can be found in ORC Macro and USAID’s Women’s Lives and Experiences: Changes in the Past Ten Years (Research Findings from the Demographic and Health Surveys). Childhood malaria mortality data was accessed in 2003 from the United Nations Statistics Divisions’ Millennium Indicators. Tuberculosis data was obtained from the United Nations Statistics Division’s Millennium Indicators: MDGInfo 2006. In some cases information was unavailable.

 
           
             
  Ghana has approximately 1 hospital bed per 638 population, and 1 physician per 22,970 population. The northern region of the country has fewer health resources compared to the coastal region and the capital.

About 40 percent of Ghana's health care services are provided by faith-based NGOs represented by the Christian Health Association of Ghana (CHAG). 49 hospitals and 75 clinics are connected to the CHAG network.

Ghana's most advanced hospitals are the two teaching hospitals, Korle-Bu located in the capital city of Accra, and Komfo Anokye in Kumasi. Ghana's AIDS Commission plans to launch an anti-retroviral pilot program in January 2004 at Korle-Bu and Komfo Anokye teachijng hospitals, and also St. Martin's Hospital and Manya-Krobo. The NGO Info-Ghana provides contact information for around 18 hospitals.

Sources: World Bank health sector assessment, Swishweb, Info-Ghana

 
           
             
 

Centre for Tropical Clinical Pharmacology and Therapeutics

Komfo Anokye Teaching Hospital

An ARV pilot project is scheduled to begin at Komfo Anokye hospital in January, 2004.

Korle-bu Teaching Hospital

An ARV pilot project is scheduled to begin at Korle-bu hospital in January, 2004.

Navrongo Health Research Center

Navrongo Health Research Center is a medical research institute operated by Ghana's Ministry of Health. It is located in a rural location in the northern part of the country.

Noguchi Memorial Institute for Medical Research

Founded in 1979 with assistance from Japan, the Noguchi Memorial Institute is located at the University of Ghana in Accra. Named after a Japanese scientist who specialized in the study of yellow fever, the Institute conducts research related to communicable diseases common in Ghana. Noguchi Institute has partnered with MIM/TDR as the home site for the Antimalarial Drug Resistance Network in Ghana.

Severe Malaria in African Children (SMAC) site ( website )

Ghana is host to one of five centers in the SMAC clinical trials network.

 
           
             
 

Entity

Project Title

Diseases

Primary Category

Secondary Category

NIH CS DNA MVA Trial in Mampong, Ghana Malaria Drug Development Prevention
  National Institute of Allergy and Infectious Diseases (NIAID)and Noguchi Memorial Institute of Medical Research. This Phase 1 trial will examine...

NIH Optimal Child Nutrition in HIV-Affected Communities HIV/AIDS Epidemiology  
  (Principal Investigator: Grace Marquis. 2002-2007.) This study is examining the impact of the HIV/AIDS epidemic on child nutrition in Ghana.

Other US Partially-Blind (Observer-Blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children Malaria Drug Development Prevention
  GlaxoSmithKline with the Malaria Vaccine Initiative at PATH. The purpose of the study is to evaluate the safety and immunogenicity of two different...

Other US USAID HIV/AIDS,Malaria General  
  The United States has launched a US $25 million aid programme through USAID in northern Ghana that includes help for people living with HIV/AIDS,...

International Anti-Herpetic Treatment of Genital Ulcer: Effect on HIV and Herpes Shedding (ANRS 1212) HIV/AIDS Drug Development Prevention
  French National Agency for Research on AIDS and Viral Hepatitis (Study Chairs: Laurent Belec and Philippe Mayaud. PI: Gerard Gresenguet). This...

International World Health Organization Malaria Drug Development  
  The World Health Organization and the Roll Back Malaria program are funding the following project:

"Impact of intermittent treatment of malaria...

International Randomized Trial on Effectiveness of ACTs in Ghana Malaria Drug Development  
  Bernhard Nocht Institute for Tropical Medicine, Presbyterian Health Service, Kumasi Centre for Collaborative Research, School of Medical Sciences...

International Chlorproguanil-Dapsone-Artesunate (CDA) Versus COARTEM for Uncomplicated Malaria Malaria Drug Development  
  GlaxoSmithKline, Medicines for Malaria Venture, WHO. The combination of chlorproguanil-dapsone-artesunate for the treatment of uncomplicated...

International Effects of Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomized Control Trial (RDT-ACT) Malaria Drug Development Capacity
  Kintampo Health Research Centre, Ghana; ACT Consortium; London School of Hygiene and Tropical Medicine (PIs: Frank Baiden, Jane Webster, Kwaku...

International Safe and Efficacious Artemisinin-Based Combination Treatments for African Pregnant Women with Malaria (PREGACT) Malaria Drug Development  
  Institute of Tropical Medicine, Belgium; Seattle Institute for Biomedical and Clinical Research; National Institute for Medical Research, Tanzania;...

International Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa Malaria Drug Development  
  GlaxoSmithKline will conduct this clinical trial at its investigational sites in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique, and...

International Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) for Uncomplicated Malaria Malaria Drug Development  
  GlaxoSmithKline, Medicines for Malaria Venture, and World Health Organization. This phase III study of the efficacy and safety of a malaria...

International MIM/TDR Grants for Malaria Research Malaria Epidemiology  
  A Mulitilateral Initiative on Malaria (MIM)/TDR Task Force awarded two grants for malaria research in Ghana in 2002. Together the grants represented...

International European Community Malaria Epidemiology  
  The European Community is funding a study comparing immunities to malaria in Ghana and Sudan. Malaria is endemic at the study site in Ghana. At the...

International CIDA (Canada) HIV/AIDS Prevention  
  CIDA's AIDS 3 project in Ghana will continue its work in preventing the spread of HIV through commercial sex work. Six cities are currently covered...

International Japan Malaria Prevention  
  The government of Japan has contributed a total of US$1,063,813 to the Infectious Disease Prevention Project in Ghana which will make it possible...

International The Synergistic Effects of Home-Management and Intermittent Preventive Treatment of Malaria in Children Malaria Prevention  
  Kwame Nkrumah University of Science and Technology; Department for International Development, United Kingdom; UK: Malaria Consortium; Center for...

International Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana Malaria Prevention General
  The Hospital for Sick Children, Canada (PI: Stanley H. Zlotkin). Researchers in this randomized, double-blind trial are investigating the impact...

International World Bank HIV/AIDS,Tuberculosis,Malaria General  
  The World Bank currently has two health sector projects in Ghana: an AIDS response project, and a more generalized health sector support project....

International Germany (GTZ) HIV/AIDS General  
  GTZ is one of several international donors providing funding support for Ghana's AIDS Commission.

Source: AllAfrica.com interview with Prof....

International Netherlands HIV/AIDS General  
  The Netherlands embassy to Ghana is one of several international donors providing funding support for Ghana's AIDS Commission.

Source:...

International Denmark (DANIDA) HIV/AIDS General  
  DANIDA is one of several international donors providing funding support for Ghana's AIDS Commission.

Source: AllAfrica.com interview with Prof....

International Global Fund for AIDS, Tuberculosis and Malaria (GFATM) HIV/AIDS,Tuberculosis,Malaria General  
  GFATM has awarded grants to fight all three major diseases in Ghana. All of these grants are administered by Ghana's Ministry of Health. Altogether...

International Japan HIV/AIDS,Tuberculosis,Malaria General  
  In FY 2002 Japan made a grant of 100 million yen to support UNICEF's Project for Infectious Disease Prevention for Children in Ghana.

Source: ...

International DFID (The United Kingdom) Malaria General  
  DFID supports the following project in Ghana:
  • "EPI-linked malaria chemotherapy and iron supplementation trial." Principal Investigator:
...

International Compliance to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana Malaria General  
  Kintampo Health Research Centre, London School of Hygiene and Tropical Medicine, with support from the Gates Malaria Partnership (PIs: Seth...

Foundation Effect of Malaria on Disease Progression of HIV/AIDS HIV/AIDS,Malaria Drug Development Prevention
  Gates Malaria Partnership (PI: Ruby Martin-Peprah). This study will test the hypothesis that intermittent malaria treatment will slow the decline...

Foundation Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana Malaria Drug Development Prevention
  Gates Malaria Partnership; London School of Hygiene and Tropical Medicine; Navrongo Health Research Center, Ghana; Kintampo Health Research Centre,...

Foundation Effectiveness of Intermittent Preventive Treatment for Malaria in Children Malaria Drug Development Prevention
  Gates Malaria Partnership (PIs: Margaret Kweku, Daniel Chandramohan, Brian Greenwood). This study will evaluate the effectiveness of Intermittent...

Foundation Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy Malaria Drug Development Prevention
  Gates Malaria Partnership with Kwame Nkrumah University of Science and Technology (PIs: Harry Tagbor, Brian Greenwood, Daniel Chandramohan, Jane...

Foundation Kintampo Antimalarial Drug Trial Malaria Drug Development  
  A Non-Inferiority, Open-Labelled, Randomized Trial of the Efficacy and Safety of Artesunate-Amodiquine, Artemether-Lumefantrine, and...

Foundation Navrongo Drug Options for IPT in Pregnancy Trial Malaria Drug Development Prevention
  Gates Malaria Partnership (PIs: Christine Clerk, Daniel Chandramohan, Brian Greenwood). The study seeks to evaluate standard and alternative...

Foundation Wellcome Trust Malaria Epidemiology  
  Wellcome Trust is funding a significant body of research in Ghana under the direction of Professor Eleanor Riley of the London School of Hygiene and...

Foundation Control of Pregnancy Associated Malaria with Intermittent Preventive Treatment Malaria Prevention Capacity
  DBL - Institute for Health research and Development. (PI: Victoria Bam) This study seeks to evaluate different methodologies for providing...

 
           
             
 
  1. GFATM has approved a grant for $18.5 million to fight malaria in Ghana. The grant agreement has yet to be signed.

    Source: GFATM portfolio of grants in Ghana

 
           



Home || HIV/AIDS || Tuberculosis || Malaria || Advanced Search || Links || Contact Us

Last site update: November 17, 2009

For questions, or to report problems with this site, please contact the Webmaster.

Disclaimer